| Prazosin | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
| Prazosin | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | |
| Prazosin | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | |
| Prazosin | hsa00512 | Mucin type O-glycan biosynthesis | 4.86E-02 | 2 | O95395, Q9NY28 | GCNT3, GALNT8 | More | |
| Prazosin | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
| Prazosin | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
| Prazosin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.04E-05 | 2 | P40925, P15104 | MDH1, GLUL | More | |
| Prazosin | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
| Prazosin | hsa00830 | Retinol metabolism | 3.15E-02 | 1 | P00325 | ADH1B | More | |
| Prazosin | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Prazosin | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
| Prazosin | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.28E-02 | 1 | P22307 | SCP2 | More | |
| Prazosin | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
| Prazosin | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | |
| Prazosin | hsa01524 | Platinum drug resistance | 4.95E-03 | 3 | P78417, P52701, P31751 | GSTO1, MSH6, AKT2 | More | |
| Prazosin | hsa02010 | ABC transporters | 4.48E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Prazosin | hsa03020 | RNA polymerase | 1.64E-03 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | |
| Prazosin | hsa03040 | Spliceosome | 1.34E-03 | 9 | Q14562, O43143, O60508, P08579, Q07955, Q01130, Q13243, P11142, O43447 | DHX8, DHX15, CDC40, SNRPB2, SFRS1, SFRS2, SFRS5, HSPA8, PPIH | More | |
| Prazosin | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | |
| Prazosin | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | |
| Prazosin | hsa04014 | Ras signaling pathway | 1.21E-03 | 8 | P31751, Q9NRA1, Q13009, P0DP23, P62873, P63218, P50151, P19174 | AKT2, PDGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | |
| Prazosin | hsa04015 | Rap1 signaling pathway | 6.14E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
| Prazosin | hsa04020 | Calcium signaling pathway | 8.77E-03 | 3 | P21796, P30679, P23634 | VDAC1, GNA15, ATP2B4 | More | |
| Prazosin | hsa04022 | cGMP-PKG signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
| Prazosin | hsa04024 | cAMP signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
| Prazosin | hsa04062 | Chemokine signaling pathway | 1.59E-03 | 9 | P07948, P19174, P62873, P63218, P50151, Q13009, P14598, P42224, P25963 | LYN, PLCG1, GNB1, GNG5, GNG10, TIAM1, NCF1, STAT1, NFKBIA | More | |
| Prazosin | hsa04064 | NF-kappa B signaling pathway | 1.27E-04 | 15 | P10415, O00463, P01584, P01375, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q13315, P63279, P24522, Q8NHW4, P09341, Q9NQC7 | BCL2, TRAF5, IL1B, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CYLD | More | |
| Prazosin | hsa04070 | Phosphatidylinositol signaling system | 2.32E-03 | 5 | P19174, P0DP23, P23743, P49619, P27987 | PLCG1, CALM1, DGKA, DGKG, ITPKB | More | |
| Prazosin | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 4 | P21453, Q9H228, P01375, Q13362 | S1PR1, EDG8, TNF, PPP2R5C | More | |
| Prazosin | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | |
| Prazosin | hsa04110 | Cell cycle | 2.90E-02 | 5 | P06493, P30304, P33981, P01106, Q13547 | CDK1, CDC25A, TTK, MYC, HDAC1 | More | |
| Prazosin | hsa04114 | Oocyte meiosis | 6.23E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | |
| Prazosin | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
| Prazosin | hsa04140 | Autophagy - animal | 4.55E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | |
| Prazosin | hsa04141 | Protein processing in endoplasmic reticulum | 8.60E-03 | 6 | P30101, P60604, P11142, P08238, Q9H173, Q9UNL2 | PDIA3, UBE2G2, HSPA8, HSP90AB1, SIL1, SSR3 | More | |
| Prazosin | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | |
| Prazosin | hsa04144 | Endocytosis | 1.67E-02 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | |
| Prazosin | hsa04145 | Phagosome | 9.75E-04 | 13 | O75015, P11215, Q15080, P14598, Q71U36, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765 | FCGR3B, ITGAM, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | |
| Prazosin | hsa04213 | Longevity regulating pathway - multiple species | 3.14E-03 | 5 | Q9Y4H2, Q08828, P51828, P0DMV8, Q13547 | IRS2, ADCY1, ADCY7, HSPA1A, HDAC1 | More | |
| Prazosin | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | |
| Prazosin | hsa04218 | Cellular senescence | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
| Prazosin | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.83E-03 | 6 | P07550, P22694, P31751, P18848, Q13362, P0DP23 | ADRB2, PRKACB, AKT2, ATF4, PPP2R5C, CALM1 | More | |
| Prazosin | hsa04270 | Vascular smooth muscle contraction | 6.96E-03 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | |
| Prazosin | hsa04310 | Wnt signaling pathway | 5.60E-03 | 3 | P30279, Q13485, O43318 | CCND2, SMAD4, MAP3K7 | More | |
| Prazosin | hsa04370 | VEGF signaling pathway | 4.61E-04 | 4 | P16298, P31751, Q05397, Q02750 | PPP3CB, AKT2, PTK2, MAP2K1 | More | |
| Prazosin | hsa04371 | Apelin signaling pathway | 5.24E-05 | 8 | P62873, P63218, P50151, P31751, Q13370, Q14344, P84022, P0DP23 | GNB1, GNG5, GNG10, AKT2, PDE3B, GNA13, SMAD3, CALM1 | More | |
| Prazosin | hsa04380 | Osteoclast differentiation | 2.11E-03 | 2 | Q9NQC7, P31751 | CYLD, AKT2 | More | |
| Prazosin | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | |
| Prazosin | hsa04520 | Adherens junction | 3.91E-02 | 2 | Q13485, O43318 | SMAD4, MAP3K7 | More | |
| Prazosin | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
| Prazosin | hsa04540 | Gap junction | 1.08E-02 | 4 | Q13509, P68371, Q71U36, Q9NRA1 | TUBB3, TUBB2C, TUBA1A, PDGFC | More | |
| Prazosin | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 4.73E-02 | 3 | Q13873, Q02750, Q86SE9 | BMPR2, MAP2K1, PCGF5 | More | |
| Prazosin | hsa04610 | Complement and coagulation cascades | 1.91E-03 | 1 | P0C0L4 | C4A | More | |
| Prazosin | hsa04612 | Antigen processing and presentation | 3.33E-04 | 8 | P13765, P48382, Q14953, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | |
| Prazosin | hsa04613 | Neutrophil extracellular trap formation | 7.27E-06 | 9 | P19174, P11215, Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | PLCG1, ITGAM, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Prazosin | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | |
| Prazosin | hsa04623 | Cytosolic DNA-sensing pathway | 6.63E-04 | 4 | P01584, P01568, P25963, Q8NHW4 | IL1B, IFNA21, NFKBIA, CCL4L2 | More | |
| Prazosin | hsa04625 | C-type lectin receptor signaling pathway | 1.38E-05 | 3 | Q9NQC7, P31751, P0DP23 | CYLD, AKT2, CALM1 | More | |
| Prazosin | hsa04630 | JAK-STAT signaling pathway | 3.20E-02 | 4 | P01106, P42224, P14784, Q13651 | MYC, STAT1, IL2RB, IL10RA | More | |
| Prazosin | hsa04640 | Hematopoietic cell lineage | 4.72E-02 | 8 | P13612, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | |
| Prazosin | hsa04650 | Natural killer cell mediated cytotoxicity | 3.53E-06 | 13 | P16298, P50591, P01375, P06239, O60880, P20963, Q02750, Q13241, P26718, O75015, P26717, Q14953, P26715 | PPP3CB, TNFSF10, TNF, LCK, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | |
| Prazosin | hsa04657 | IL-17 signaling pathway | 2.41E-02 | 4 | P19875, P14780, P80188, P01375 | CXCL2, MMP9, LCN2, TNF | More | |
| Prazosin | hsa04658 | Th1 and Th2 cell differentiation | 8.66E-06 | 13 | Q04759, P07766, P20963, P09693, P19174, P06239, P42224, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | |
| Prazosin | hsa04659 | Th17 cell differentiation | 2.13E-05 | 15 | P25963, Q04759, P19174, P06239, P42224, P14784, P13765, Q9HBE5, Q9UL17, P23771, P84022, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL21R, TBX21, GATA3, SMAD3, HSP90AB1, CD3E, CD3G, CD247 | More | |
| Prazosin | hsa04660 | T cell receptor signaling pathway | 4.75E-03 | 10 | P01375, Q9UDY8, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, P06239 | TNF, MALT1, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, LCK | More | |
| Prazosin | hsa04662 | B cell receptor signaling pathway | 1.60E-04 | 6 | P31751, P42338, P60033, P07948, P21854, Q8N149 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2 | More | |
| Prazosin | hsa04664 | Fc epsilon RI signaling pathway | 1.05E-04 | 6 | P31751, P04141, P42338, P07948, P19174, P09917 | AKT2, CSF2, PIK3CB, LYN, PLCG1, ALOX5 | More | |
| Prazosin | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | |
| Prazosin | hsa04713 | Circadian entrainment | 2.18E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | |
| Prazosin | hsa04720 | Long-term potentiation | 2.85E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | |
| Prazosin | hsa04722 | Neurotrophin signaling pathway | 1.26E-03 | 5 | P31751, P49841, O43524, P48023, P0DP23 | AKT2, GSK3B, FOXO3, FASLG, CALM1 | More | |
| Prazosin | hsa04724 | Glutamatergic synapse | 2.58E-04 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | |
| Prazosin | hsa04725 | Cholinergic synapse | 4.10E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | |
| Prazosin | hsa04726 | Serotonergic synapse | 3.80E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | |
| Prazosin | hsa04727 | GABAergic synapse | 1.66E-04 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | |
| Prazosin | hsa04728 | Dopaminergic synapse | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
| Prazosin | hsa04730 | Long-term depression | 4.86E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | |
| Prazosin | hsa04740 | Olfactory transduction | 9.46E-04 | 2 | Q9H255, P0DP23 | OR51E2, CALM1 | More | |
| Prazosin | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | |
| Prazosin | hsa04744 | Phototransduction | 1.51E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
| Prazosin | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.01E-02 | 4 | P01584, Q08828, P51828, P0DP23 | IL1B, ADCY1, ADCY7, CALM1 | More | |
| Prazosin | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | |
| Prazosin | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | |
| Prazosin | hsa04914 | Progesterone-mediated oocyte maturation | 1.00E-02 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | |
| Prazosin | hsa04915 | Estrogen signaling pathway | 3.76E-03 | 6 | Q08828, P51828, P31751, P0DMV8, P0DP23, Q15788 | ADCY1, ADCY7, AKT2, HSPA1A, CALM1, NCOA1 | More | |
| Prazosin | hsa04916 | Melanogenesis | 4.78E-02 | 1 | P0DP23 | CALM1 | More | |
| Prazosin | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa04919 | Thyroid hormone signaling pathway | 1.64E-02 | 4 | P19174, P42224, Q13547, P01106 | PLCG1, STAT1, HDAC1, MYC | More | |
| Prazosin | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa04922 | Glucagon signaling pathway | 1.79E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
| Prazosin | hsa04923 | Regulation of lipolysis in adipocytes | 3.01E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa04924 | Renin secretion | 6.02E-03 | 3 | P22694, P07550, P0DP23 | PRKACB, ADRB2, CALM1 | More | |
| Prazosin | hsa04926 | Relaxin signaling pathway | 6.18E-05 | 9 | P42338, P63218, P50151, P18848, P22694, P49767, P14780, P30679, P49407 | PIK3CB, GNG5, GNG10, ATF4, PRKACB, VEGFC, MMP9, GNA15, ARRB1 | More | |
| Prazosin | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | |
| Prazosin | hsa04929 | GnRH secretion | 3.61E-03 | 3 | P42338, P31751, P49407 | PIK3CB, AKT2, ARRB1 | More | |
| Prazosin | hsa04932 | Non-alcoholic fatty liver disease | 7.56E-04 | 9 | P01375, P49841, O43521, P48023, O75460, P01584, P13073, P12074, O95298 | TNF, GSK3B, BCL2L11, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFC2 | More | |
| Prazosin | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Prazosin | hsa04964 | Proximal tubule bicarbonate reclamation | 4.48E-02 | 1 | P00918 | CA2 | More | |
| Prazosin | hsa04966 | Collecting duct acid secretion | 4.48E-02 | 1 | P00918 | CA2 | More | |
| Prazosin | hsa04970 | Salivary secretion | 5.38E-04 | 6 | P07550, Q08828, P51828, P22694, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, CALM1, CAMP | More | |
| Prazosin | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | |
| Prazosin | hsa04972 | Pancreatic secretion | 1.31E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | |
| Prazosin | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa04976 | Bile secretion | 4.78E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | |
| Prazosin | hsa05010 | Alzheimer disease | 8.59E-04 | 3 | Q00535, P0DP23, P31751 | CDK5, CALM1, AKT2 | More | |
| Prazosin | hsa05012 | Parkinson disease | 1.77E-02 | 6 | P60604, P19174, P0DP23, Q71U36, Q13509, P68371 | UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3, TUBB2C | More | |
| Prazosin | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | |
| Prazosin | hsa05017 | Spinocerebellar ataxia | 2.16E-02 | 2 | Q8TB72, P21796 | PUM2, VDAC1 | More | |
| Prazosin | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.60E-03 | 4 | Q06055, Q00535, O15020, P0DP23 | ATP5G2, CDK5, SPTBN2, CALM1 | More | |
| Prazosin | hsa05030 | Cocaine addiction | 4.19E-02 | 1 | Q00535 | CDK5 | More | |
| Prazosin | hsa05031 | Amphetamine addiction | 6.98E-03 | 4 | P0DP23, P22694, P18848, Q13547 | CALM1, PRKACB, ATF4, HDAC1 | More | |
| Prazosin | hsa05032 | Morphine addiction | 2.18E-02 | 4 | P62873, P63218, P50151, Q13370 | GNB1, GNG5, GNG10, PDE3B | More | |
| Prazosin | hsa05034 | Alcoholism | 6.34E-06 | 7 | Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Prazosin | hsa05100 | Bacterial invasion of epithelial cells | 2.85E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | |
| Prazosin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.08E-02 | 4 | P25963, Q13488, P19174, P07948 | NFKBIA, TCIRG1, PLCG1, LYN | More | |
| Prazosin | hsa05130 | Pathogenic Escherichia coli infection | 3.19E-02 | 6 | Q71U36, P16333, Q13509, P68371, Q14344, P25963 | TUBA1A, NCK1, TUBB3, TUBB2C, GNA13, NFKBIA | More | |
| Prazosin | hsa05132 | Salmonella infection | 2.75E-02 | 7 | P25963, P08238, O75369, Q71U36, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, FLNB, TUBA1A, TUBB3, TUBB2C, VPS41 | More | |
| Prazosin | hsa05133 | Pertussis | 3.51E-02 | 1 | P0C0L4 | C4A | More | |
| Prazosin | hsa05134 | Legionellosis | 2.84E-03 | 6 | P01584, P25963, Q9NR31, P11215, P0DMV8, P11142 | IL1B, NFKBIA, SAR1A, ITGAM, HSPA1A, HSPA8 | More | |
| Prazosin | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
| Prazosin | hsa05140 | Leishmaniasis | 4.71E-03 | 10 | P13612, O75015, P14598, P11215, P42224, P13765, O60603, P25963, P01375, Q15080 | ITGA4, FCGR3B, NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, NCF4 | More | |
| Prazosin | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
| Prazosin | hsa05144 | Malaria | 6.75E-04 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | |
| Prazosin | hsa05146 | Amoebiasis | 1.64E-03 | 9 | P09341, P19875, P27930, P01375, O60603, P05089, P30679, P22694, P08311 | CXCL1, CXCL2, IL1R2, TNF, TLR2, ARG1, GNA15, PRKACB, CTSG | More | |
| Prazosin | hsa05150 | Staphylococcus aureus infection | 1.31E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | |
| Prazosin | hsa05152 | Tuberculosis | 9.92E-03 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | |
| Prazosin | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
| Prazosin | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | |
| Prazosin | hsa05163 | Human cytomegalovirus infection | 1.02E-04 | 15 | P31751, P25963, P62873, P63218, P50151, P0DP23, Q14344, Q8NHW4, Q08828, P51828, P23458, P01584, Q13651, P30101, P01568 | AKT2, NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, IL10RA, PDIA3, IFNA21 | More | |
| Prazosin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.91E-06 | 11 | P01568, P31751, P42224, P25963, P62873, P63218, P50151, P19174, P07948, P04141, P0DP23 | IFNA21, AKT2, STAT1, NFKBIA, GNB1, GNG5, GNG10, PLCG1, LYN, CSF2, CALM1 | More | |
| Prazosin | hsa05168 | Herpes simplex virus 1 infection | 3.79E-02 | 9 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, ZNF211, ZNF189 | More | |
| Prazosin | hsa05169 | Epstein-Barr virus infection | 3.90E-03 | 8 | P01106, Q13547, P42338, P07948, Q13761, O75293, P42224, P07766 | MYC, HDAC1, PIK3CB, LYN, RUNX3, GADD45B, STAT1, CD3E | More | |
| Prazosin | hsa05170 | Human immunodeficiency virus 1 infection | 7.83E-04 | 9 | P31751, P62873, P63218, P50151, P0DP23, P30101, P01568, P25963, P19174 | AKT2, GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, NFKBIA, PLCG1 | More | |
| Prazosin | hsa05200 | Pathways in cancer | 1.44E-05 | 20 | P08238, P42224, P25963, P19174, P43246, P84022, Q13485, P20585, P52701, P30279, P31751, P62873, P63218, P50151, Q14344, P78417, O75293, P0DP23, P01568, P14784 | HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, SMAD4, MSH3, MSH6, CCND2, AKT2, GNB1, GNG5, GNG10, GNA13, GSTO1, GADD45B, CALM1, IFNA21, IL2RB | More | |
| Prazosin | hsa05202 | Transcriptional misregulation in cancer | 2.90E-03 | 15 | Q13315, P14780, P27930, Q15744, Q16548, P11215, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, Q13547, P12980, P24522 | ATM, MMP9, IL1R2, CEBPE, BCL2A1, ITGAM, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | |
| Prazosin | hsa05203 | Viral carcinogenesis | 3.91E-05 | 8 | Q13547, Q15283, P12814, P06493, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, ACTN1, CDK1, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | |
| Prazosin | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Prazosin | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | |
| Prazosin | hsa05210 | Colorectal cancer | 4.94E-02 | 2 | Q13485, P52701 | SMAD4, MSH6 | More | |
| Prazosin | hsa05211 | Renal cell carcinoma | 4.78E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05212 | Pancreatic cancer | 1.19E-02 | 4 | P31751, P42224, P84022, O75293 | AKT2, STAT1, SMAD3, GADD45B | More | |
| Prazosin | hsa05213 | Endometrial cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05214 | Glioma | 1.23E-03 | 4 | P0DP23, P31751, P19174, O75293 | CALM1, AKT2, PLCG1, GADD45B | More | |
| Prazosin | hsa05218 | Melanoma | 3.01E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05220 | Chronic myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05221 | Acute myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05223 | Non-small cell lung cancer | 2.41E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05226 | Gastric cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05230 | Central carbon metabolism in cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | |
| Prazosin | hsa05231 | Choline metabolism in cancer | 1.39E-02 | 3 | Q9Y259, P19174, P49619 | CHKB, PLCG1, DGKG | More | |
| Prazosin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.46E-03 | 5 | P19174, P07766, P06239, P42224, Q9HC35 | PLCG1, CD3E, LCK, STAT1, EML4 | More | |
| Prazosin | hsa05310 | Asthma | 1.92E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | |
| Prazosin | hsa05321 | Inflammatory bowel disease | 1.17E-05 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | |
| Prazosin | hsa05322 | Systemic lupus erythematosus | 8.69E-07 | 8 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431, P12814 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1 | More | |
| Prazosin | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Prazosin | hsa05332 | Graft-versus-host disease | 7.00E-05 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | |
| Prazosin | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.48E-02 | 1 | P54284 | CACNB3 | More | |
| Prazosin | hsa05414 | Dilated cardiomyopathy | 4.55E-02 | 2 | P54284, P26678 | CACNB3, PLN | More | |
| Prazosin | hsa05418 | Fluid shear stress and atherosclerosis | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
